Versiti
Versiti is a nonprofit, 501(c)(3) blood health organization dedicated to improving patient lives and supporting healthcare partners through blood donation, innovative research, and advanced diagnostic testing. With locations across the Midwest, Versiti is a leader in blood health innovation, organ and tissue donation, and precision medicine. The organization is committed to enhancing patient care, advancing healthcare standards, and fostering a vibrant donor community. Versiti also supports education through scholarships and is recognized for its compliance and accreditations.
Versiti
What We Do
A laboratory-developed test for ABO/Rh, Direct Antiglobulin Test, and antibody identification, used in the evaluation of immune-mediated red cell destruction.
A laboratory-developed test to determine when antibodies attack a person's own red blood cells, leading to hemolytic anemia.
A standard test for pretransfusion donor and patient compatibility and diagnosis, using universally accepted serological methods.
A panel for detection of germline variants in 22 genes causing thrombocytopenia, using NGS and aCGH methodologies.
Genotyping for the Rh C and c antigen, used in the context of hemolytic disease of the newborn or fetus. Laboratory developed test using allele-specific PCR.
A laboratory-developed test that measures antibodies inhibiting ADAMTS13 function, used in the diagnosis of Thrombotic Thrombocytopenic Purpura (TTP).
Battlefield Resuscitation
Infectious Diseases
Digital Health Technologies
FDA Regulated Medical Devices
Key People
Chief of Staff
EVP and Chief Human Resources Officer
VP and Chief Quality Officer
VP of Versiti Organ and Tissue
EVP Medical Sciences Institute and Chief Medical Officer
EVP and Chief Laboratory Officer
News & Updates
Jessica Drouillard, VP and Chief Quality Officer, was among the first in the nation to earn the CABP credential from the Association for the Advancement of Blood & Biotherapies (AABB) in 2022.